Neurodegenerative Diseases Clinical Trials

161 clinical trials for Neurodegenerative Diseases across international registries, including 37 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Memory Deterioration in Alzheimer Disease — RECRUITING
• Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS) — RECRUITING · NA
• Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases — RECRUITING · PHASE4
• Neurologic Stem Cell Treatment Study — RECRUITING · NA
• Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia — RECRUITING · NA
• Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia — RECRUITING · NA
• Retinal Hyperspectral Imaging in Neurodegenerative Diseases — RECRUITING · NA
• A Phase 3 Study of NTLA-2001 in ATTRv-PN — RECRUITING · PHASE3
• Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) — RECRUITING
• Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity — RECRUITING · NA
• Normal Chinese Lifespan Brain Charts Initiative (NCLBCI) — RECRUITING
• Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality — RECRUITING
• Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside — RECRUITING
• Longitudinal Investigation of I2BS in PD — RECRUITING
• Serotonin Release in Premotor and Motor PD — RECRUITING
• Molecular and Functional Imaging in Monogenic PD. — RECRUITING
• Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR — RECRUITING
• Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families — RECRUITING · NA
• Saliva and Extracellular Vesicles for Neurodegenerative Diseases — RECRUITING
• Beta Amyloid PET/CT in Various Aβ-Related Disease — RECRUITING
• Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands — RECRUITING · NA
• Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis — RECRUITING
• Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases — RECRUITING
• Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study — RECRUITING
• Home Exercise for Individuals with Neurodegenerative Disease — RECRUITING · NA
• Observational Pharmaco-Epidemiology Research & Analysis — RECRUITING
• Tau PET/CT in Various Tau-Related Disease Patients — RECRUITING
• Translocator Protein PET/CT in Various TSPO-Related Disease — RECRUITING
• Simulation-informed Modelling and Personalized Evaluation (SIMPLE) in Ageing Populations — RECRUITING
• Probiotics in Mild Alzheimer's Disease — RECRUITING · PHASE1
• A Low-Cost Balance Training Platform Using Augmented Reality in Neurorehabilitation: a Usability Study — RECRUITING · NA
• Neurodegenerative Diseases Progression Markers (MARKERS-NDD) — RECRUITING
• Blood And Tears in Alzheimer's Disease — RECRUITING
• Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population — RECRUITING · NA
• New CSF Biomarkers for Alzheimer's Disease — RECRUITING
• Shanghai At Risk for Alzheimer's Disease: a Cohort Study — RECRUITING
• THE BRAIN-EYE AMYLOID MEMORY (BEAM) STUDY: VALADATION OF OCULAR MEASURES AS POTENTIAL BIOMARKERS FOR EARLY DETECTION AMYLOID AND NEURODEGENERATION — RECRUITING
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study — ACTIVE_NOT_RECRUITING
• Impact of Harp Therapy on Behavioral Disorders in Nursing Home Residents With Neurodegenerative Disease (ARPE) — COMPLETED
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) — ACTIVE_NOT_RECRUITING · PHASE3
• Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation — COMPLETED · PHASE2
• Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride Camera — COMPLETED
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) — ACTIVE_NOT_RECRUITING · PHASE3
• AMX0035 and Progressive Supranuclear Palsy — COMPLETED · PHASE2
• Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION — ACTIVE_NOT_RECRUITING
• A PHASE 3 OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY AND EFFICACY OF ORALLY ADMINISTERED NNZ-2591 IN PEDIATRIC PARTICIPANTS WITH PHELAN-MCDERMID SYNDROME — NOT_YET_RECRUITING · PHASE3
• Novel Technologies to Measure Vision-related Quality of Life — NOT_YET_RECRUITING
• Study on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases — NOT_YET_RECRUITING · PHASE1
• NAD+ Oral Supplement Pilot Intervention in Adult Females — COMPLETED · NA

Refine this search